SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000918066-03-000014
Filing Date
2003-12-23
Accepted
2003-12-23 11:30:30
Documents
1
Period of Report
2003-12-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT c0001206361d20031223f4f.html 4  
1 PRIMARY DOCUMENT c0001206361d20031223f4f.xml 4 8994
  Complete submission text file 0000918066-03-000014.txt   10817
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GUILFORD PHARMACEUTICALS INC 6611 TIBUTARY ST. BALTIMORE MD 21224
Business Address 6611 TRIBUTARY STREET C/O GUILFORD PHARMACEUTICALS INC BALTIMORE MD 21224 4106316300
BUNTING GEORGE L JR (Reporting) CIK: 0001206361 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23736 | Film No.: 031069868